剂型TABLET 给药途径ORAL 市场类别NDA AUTHORIZED GENERIC 申请号NDA018276 标签持有者Aphena Pharma Solutions - Tennessee, LLC 活性成分ALPRAZOLAM 规格1 mg/1 药学分类Benzodiazepine [EPC], Benzodiazepines [CS] DEA计划编号CIV 上市认证有效期20251231 <<-药品包装规格及说明书信息->> ...
1 药品名称 ALPRAZOLAM 申请号 074046 产品号 001 活性成分 ALPRAZOLAM 市场状态 处方药 剂型或给药途径 TABLET;ORAL 规格 0.25MG 治疗等效代码 AB 参比药物 否 批准日期 1993/10/19 申请机构 MYLAN PHARMACEUTICALS INC 2 药品名称 ALPRAZOLAM 申请号 074046 产品号 002 活性成分 ALPRAZOLAM 市场状态 处方药 剂型...
1 mg/mL oral solution 0.5 mg, 1mg, 2 mg, 3 mg extended-release oral tablets 0.25 mg, 0.5 mg, 1mg, 2 mg oral tablets How should I store alprazolam? Oral Tablet. Alprazolam tablets should be stored at room temperature, between 68 F to 77 F (20 C to 25 C). It can be exposed ...
1 mg/mL oral solution 0.5 mg, 1mg, 2 mg, 3 mg extended-release oral tablets 0.25 mg, 0.5 mg, 1mg, 2 mg oral tablets How should I store alprazolam? Oral Tablet. Alprazolam tablets should be stored at room temperature, between 68 F to 77 F (20 C to 25 C). It can be exposed ...
The recommended starting oral dosage of alprazolam for the treatment of PD is 0.5 mg three times daily. Depending on the response, the dosage may be increased at intervals of every 3 to 4 days in increments of no more than 1 mg per day. ...
加速批准 常规显示 历史记录 首页 > 美国上市药品 > 当前位置 基本信息 申请号 074479 申请类型 ANDA 商品名 Alprazolam 活性成分 Alprazolam 中文名称 阿普唑仑 申请机构 Watson Labs 批准日期 1997-01-21 孤儿药 / 其他信息 开通vip,即可解锁更多内容!
美国上市药品目录集提供Alprazolam的基本信息,包括Alprazolam的申请号203346,申请类型,活性成分Alprazolam,中文名称阿普唑仑,申请机构,批准日期等药品信息,更多美国药品Alprazolam的信息查询就在戊戌数据美国上市药品数据库.
摘要:ALPRAZOLAM,TABLET, EXTENDED RELEASE; ORAL,2MG,ALPRAZOLAM 【通用名称】ALPRAZOLAM 【剂 型】TABLET, EXTENDED RELEASE; ORAL 【规 格】2MG 【活性成份】ALPRAZOLAM 【基本药物】不详本文导航: (1) ALPRAZOLAM,TABLET, EXTENDED RELEASE; ORAL,2MG,ALPRAZOLAM ...
Arrow-Alprazolam1 Oval,convexlightbluetabletmarked'A|1'and''. Eachtabletcontains1mgofalprazolam. Arrow-Alprazolam2 Rectangularwhitetabletmarked'|AI2|'andtriplescored. Eachtabletcontains2mgofalprazolam. Uses Actions Alprazolamisananti-anxietydrug.Itisabenzodiazepinederivative,chemicallyand ...
mg tablet (0.125 mg), up to four times daily on an as-needed basis, is adequate to control acute anxiety. The dosage can be titrated upward; however, fordermatologicpatients the authors rarely prescribe more than 0.25 mg three times daily. Because of the potential risk of addiction with ...